About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
- Clear all filters
- December
- Canadian Air Transport Security Authority
- Canadian Commercial Corporation
- Canadian Human Rights Commission
- Export Development Canada
- Federal Public Service Health Care Plan Administration Authority
- Health Canada
- Office of the Commissioner of Lobbying of Canada
- Toronto Port Authority
Report Type
Organization
Disposition
Year
Month
Found 415 record(s)
Req # A-2023-000675
Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_02229369, E2B_02381693, E2B_02396904, E2B_02504551, E2B_01438894, E2B_02504551, E2B_02381693, E2B_02760591, E2B_02511273, E2B_01497636.Organization: Health Canada
December 2023
Req # A-2023-000694
Adverse Drug Reactions (ADRs) for BREXPIPRAZOLE. Report numbers: E2B_06418076, E2B_06419341, E2B_06436667. ADRs for ABILIFY MAINTENA. Report numbers: E2B_06407071, E2B_06432983, E2B_06439726, E2B_06439727, E2B_06441940, E2B_06442211, E2B_06458876.Organization: Health Canada
December 2023
Req # A-2023-000700
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-104665-980.Organization: Health Canada
December 2023
Req # A-2023-000728
Adverse Drug Reactions (ADRs). Report numbers: E2B_06180779, E2B_06185519, E2B_05360214, E2B_06149321, E2B_06075952, E2B_06089952, E2B_05977659, E2B_06152358, E2B_06151903, E2B_06167563.Organization: Health Canada
December 2023
Req # A-2023-000780
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103755-563.Organization: Health Canada
December 2023
Req # A-2023-000788
Adverse Drug Reactions (ADRs). Report numbers: E2B_05874170, 001018597, 001015251, 001016200, E2B_03725133, E2B_05856387, E2B_05865692, E2B_05954104, E2B_06009141, E2B_05844058.Organization: Health Canada
December 2023
Req # A-2023-000790
Adverse Drug Reactions (ADRs). Report numbers: 000947817, 000980677, 000980680, 000980684, E2B_05137049, E2B_04942729, E2B_02969109, 000993934, E2B_05736119, E2B_05955144.Organization: Health Canada
December 2023
Req # A-2023-000809
Adverse Drug Reactions (ADRs). Report numbers: E2B_06434353, E2B_06446418, E2B_06433100, 001052208, E2B_06420188, E2B_06420189, E2B_06425030.Organization: Health Canada
December 2023
Req # A-2023-000810
Adverse Drug Reactions (ADRs). Report numbers: E2B_06428261, E2B_06426987, E2B_06449350, E2B_06448587, E2B_06446420.Organization: Health Canada
December 2023
Req # A-2023-000814
Adverse Drug Reactions (ADRs). Report numbers: E2B_02972246, E2B_02922920, 000910600, 000910011, E2B_03753030, 000953294, 000970297, 000977998, E2B_05518483, E2B_05516999.Organization: Health Canada
December 2023